Skip to main content

Together we are beating cancer

Donate now

Treatment

Showing 12 out of 1231 results
Microscopy image of Hodgkin's lymphoma

Since the 1970s, our work has helped double children's cancer survival in the UK. Here are some of our biggest achievements from the last 50 years that wouldn't have been possible without the support of our partners and supporters. Since the 1970s, our work has helped double children's cancer survival in the UK. Here are some of our biggest achievements from the last 50 years that wouldn't have been possible without the support of our partners and supporters.

by Cancer Research UK | In depth | 3 September 2024

3 September 2024

Brain scans

Stand Up To Cancer are giving two international teams each a further £3.75m to reduce the side effects of radiotherapy and make immunotherapies work for more young patients. Stand Up To Cancer are giving two international teams each a further £3.75m to reduce the side effects of radiotherapy and make immunotherapies work for more young patients.

by Tim Gunn | Analysis | 7 August 2024

7 August 2024

Two women seated in a hospital waiting room
  • Health & Medicine
  • Policy & Insight

Cancer waiting times: Who are the long waiters? 

We’re seeing a rise in ‘long waiters’ - people who wait for over 104 days to begin their cancer treatment. But who are these long waiters? We’ve recently carried out research in partnership with the National Disease Registration Service (NDRS), part of NHS England, to find out more. We’re seeing a rise in ‘long waiters’ - people who wait for over 104 days to begin their cancer treatment. But who are these long waiters? We’ve recently carried out research in partnership with the National Disease Registration Service (NDRS), part of NHS England, to find out more.

by Amy Warnock | Analysis | 16 July 2024

16 July 2024

Cancer Research UK scientists in the lab

NHS England will offer the newly-approved dabrafenib plus trametinib combination to children and young people whose gliomas are being driven by a specific genetic mutation. NHS England will offer the newly-approved dabrafenib plus trametinib combination to children and young people whose gliomas are being driven by a specific genetic mutation.

by Tim Gunn | News | 13 June 2024

13 June 2024

People at a party wearing party hats

In this third and final article in this special series about our PPI project ‘How can we share research together? A co-creation project to make scientific research more accessible’ we hear from one of the patient representatives who took part in the project, Holly Spencer. Here Holly reflects on her diagnosis, her interest in patient and public involvement and her experience of being part of this project. In this third and final article in this special series about our PPI project ‘How can we share research together? A co-creation project to make scientific research more accessible’ we hear from one of the patient representatives who took part in the project, Holly Spencer. Here Holly reflects on her diagnosis, her interest in patient and public involvement and her experience of being part of this project.

by Holly Spencer | Personal stories | 11 June 2024

11 June 2024

This entry is part 3 of 3 in the series How can we share research together?
An informational sheet highlighting how radiotherapy can be used to make radiotherapy in children more precise

A graphic designer shares their perspective on a recent patient and public involvement project during which an accessible information sheet based on a journal paper was co-created A graphic designer shares their perspective on a recent patient and public involvement project during which an accessible information sheet based on a journal paper was co-created

by Gill Brown | Analysis | 4 June 2024

4 June 2024

This entry is part 2 of 3 in the series How can we share research together?
A medical professional drawing a dose of a vaccine from a vial with a syringe

Thousands of cancer patients in England are set to gain fast-tracked access to trials of personalised cancer vaccines following the launch of a world-leading NHS trial ‘matchmaking' service Thousands of cancer patients in England are set to gain fast-tracked access to trials of personalised cancer vaccines following the launch of a world-leading NHS trial ‘matchmaking' service

by Jacob Smith | News | 31 May 2024

31 May 2024

Artwork produced as part of a patient and public involvement workshop

In this mini-series of three articles, we share a recent PPIE project where we co-created an accessible information sheet based on a journal paper. In this article the PPI co-ordinator, Lisa Whittaker and one of the researchers, Catarina Veiga give an overview of the project and share their experiences of being involved. In this mini-series of three articles, we share a recent PPIE project where we co-created an accessible information sheet based on a journal paper. In this article the PPI co-ordinator, Lisa Whittaker and one of the researchers, Catarina Veiga give an overview of the project and share their experiences of being involved.

by Lisa Whittaker, Catarina Veiga | Analysis | 28 May 2024

28 May 2024

This entry is part 1 of 3 in the series How can we share research together?